Home › Therapeutic areas › Neurology › Multiple Sclerosis
Multiple Sclerosis (12 companies)
Companies with an active program in Multiple Sclerosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | 12 |
| CLNN | Clene | Neurology Rare | 1 | Phase 3 | 5 |
| IMUX | Immunic | GI/HepatologyNeurology | 2 | Phase 3 | 4 |
| KYTX | Kyverna Therapeutics | ImmunologyNeurology+1 Rare | 1 | NDA Submitted | 7 |
| NRIX | Nurix Therapeutics | ImmunologyNeurology+1 | 1 | Phase 3 | 16 |
| OCS | Oculis Holding | NeurologyOphthalmology Rare | 1 | Phase 3 | 4 |
| DTIL | Precision Biosciences | Infectious DiseaseMetabolic+1 Rare | 1 | Phase 1 | 5 |
| PCSA | Processa Pharmaceuticals | GI/HepatologyImmunology+2 Rare | 1 | Phase 2 | 7 |
| TGTX | Tg Therapeutics | Neurology Rare | 3 | Approved | 6 |
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 1 | Approved | 29 |
| XNCR | Xencor | HematologyImmunology+4 Rare | 1 | Approved | 36 |
| ZBIO | Zenas BioPharma | DermatologyImmunology+2 Rare | 3 | NDA Submitted | 11 |
No companies match.